TRPV4 agonists attenuate the growth of cultured cholangiocytes from polycystic kidney rats and retard the formation of cysts in culture, whereas the growth of cholangiocytes from normal rats is not altered (Gradilone et al., 2010). Here, TRPV4 is linked to polycystic kidney disease.